Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 802 to 851 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
A KINDRED OF IGLON. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.099521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.379834\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011826\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NEGR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TESTIS-SPECIFIC PROTEIN TEX28. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0289523\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011765\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TEX28P2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANKYRIN-REPEAT FAMILY A PROTEIN 2 (RFXANK-LIKE 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.15014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.573028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011629\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ANKRA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ALPHA-SOLUBLE NSF ATTACHMENT PROTEIN (SNAP-ALPHA) (N-ETHYLMALEIMIDE- SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.143723\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.548537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011496\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NAPA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
27 KDA GOLGI SNARE PROTEIN (GOLGI SNAP RECEPTOR COMPLEX MEMBER 2) (MEMBRIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.1984\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.757219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011386\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GOSR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MELANOMA ANTIGEN P15 (MELANOMA-ASSOCIATED ANTIGEN RECOGNIZED BY T LYMPHOCYTES). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311416\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118856\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.262011173\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPL28\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0305282\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116515\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2620109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMCC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN KINASE C BINDING PROTEIN 1 (RACK7) (CUTANEOUS T-CELL LYMPHOMA ASSOCIATED ANTIGEN SE14-3) (CTCL TUMOR ANTIGEN SE14-3) (ZINC FINGER MYND DOMAIN CONTAINING PROTEIN 8). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0371202\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.141681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261998433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMYND8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.117829\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.450503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261549868\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRAIN PROTEIN 16. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0310375\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261549028\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
812\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.118571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.453668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261360731\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NKAP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DEAD-BOX PROTEIN ABSTRAKT HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0406169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.155406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261359922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0395402\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.151289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261355419\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXDL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL MEMBRANE PROTEIN PEX14 (PEROXIN-14) (PEROXISOMAL MEMBRANE ANCHOR PROTEIN PEX14) (PTS1 RECEPTOR DOCKING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.500223\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.91396\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261354992\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PEX14\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ETHANOLAMINE-PHOSPHATE CYTIDYLYLTRANSFERASE (EC 2.7.7.14) (PHOSPHORYLETHANOLAMINE TRANSFERASE) (CTP:PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.278946\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.06742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261327313\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PCYT2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NADH-UBIQUINONE OXIDOREDUCTASE 13 KDA-A SUBUNIT, MITOCHONDRIAL PRECURSOR (EC 1.6.5.3) (EC 1.6.99.3) (COMPLEX I-13KD-A) (CI-13KD-A). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0296703\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.113537\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.261327144\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
NDUFS6\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MYOSIN LIGHT CHAIN 1, SLOW-TWITCH MUSCLE A ISOFORM (MLC1SA) (ALKALI). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
MYL6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MYOSIN LIGHT CHAIN 1, SLOW-TWITCH MUSCLE B/VENTRICULAR ISOFORM (MLC1SB) (ALKALI). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.025294\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0967906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26132703\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MYL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MYOSIN LIGHT CHAIN 1, EMBRYONIC MUSCLE/ATRIAL ISOFORM (PRO1957). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0259096\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0991465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261326421\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MYOSIN LIGHT CHAIN 1, SKELETAL MUSCLE ISOFORM (MLC1F) (A1 CATALYTIC) (ALKALI). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0255016\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0975853\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261326245\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MYL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTOCADHERIN FAT 2 PRECURSOR (HFAT2) (MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0300014\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.114826\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261277063\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAT2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0385127\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.147402\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.261276645\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
TANC1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MLN 64 PROTEIN (STAR-RELATED LIPID TRANSFER PROTEIN 3) (STARD3) (START DOMAIN-CONTAINING PROTEIN 3) (CAB1 PROTEIN). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
STARD3\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CADHERIN-RELATED TUMOR SUPPRESSOR HOMOLOG PRECURSOR (FAT PROTEIN HOMOLOG). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MANNOSE-6-PHOSPHATE ISOMERASE (EC 5.3.1.8) (PHOSPHOMANNOSE ISOMERASE) (PMI) (PHOSPHOHEXOMUTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.482651\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.84728\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26127658\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPI\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
827\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE ANKYRIN-REPEAT CONTAINING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0298281\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.114163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261276421\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
828\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MLN64 N-TERMINAL DOMAIN HOMOLOG (STARD3 N-TERMINAL LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0299629\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.114679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261276258\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD3NL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
829\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PURINE NUCLEOSIDE PHOSPHORYLASE (EC 2.4.2.1) (INOSINE PHOSPHORYLASE) (PNP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.253043\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.969143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261099755\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
830\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KETOHEXOKINASE (EC 2.7.1.3) (HEPATIC FRUCTOKINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0303497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116238\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26109964\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KHK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
831\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MALONYL-COA DECARBOXYLASE, MITOCHONDRIAL PRECURSOR (EC 4.1.1.9) (MCD). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0344093\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.131824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261024548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MLYCD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
832\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITCHY HOMOLOG E3 UBIQUITIN PROTEIN LIGASE; ATROPHIN-1 INTERACTING PROTEIN 4; ITCHY (MOUSE HOMOLOG) E3 UBIQUITIN PROTEIN LIGASE; NFE2-ASSOCIATED POLYPEPTIDE 1; UBIQUITIN PROTEIN LIGASE ITCH. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.127743\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.489392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.261023883\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ITCH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KH-TYPE SPLICING REGULATORY PROTEIN (FUSE BINDING PROTEIN 2); KH-TYPE SPLICING REGULATORY PROTEIN (FUSE-BINDING PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.418445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.60336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260980067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KHSRP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAR UPSTREAM ELEMENT-BINDING PROTEIN; FAR UPSTREAM ELEMENT BINDING PROTEIN; FUSE-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.353001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260977665\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FUBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FUSE BINDING PROTEIN 3 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.330618\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.26685\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260976438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FUBP3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PAIRED BOX PROTEIN PAX-6 (OCULORHOMBIN) (ANIRIDIA, TYPE II PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.876793\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.36108\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260866448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAX6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
837\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.152414\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.584621\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.260705654\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC46A1\vspace{3pt}}\\\cline{1-1}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
838\vspace{3pt}}&&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SLC46A3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMININ GAMMA-1 CHAIN PRECURSOR (LAMININ B2 CHAIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.386694\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.48326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260705473\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LAMC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FEM-1 HOMOLOG B; FEM-1-LIKE DEATH RECEPTOR BINDING PROTEIN; FEM-1 (C.ELEGANS) HOMOLOG B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.845995\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.24503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FEM1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LEUCINE-RICH REPEAT PROTEIN LRRC3 PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0837034\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.321066\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704653\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LRRC3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-7 CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.077721\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.298119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704618\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHRNA7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 PRECURSOR (HLIB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0992922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.380861\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704562\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LRRC15\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ADENYLATE CYCLASE, TYPE V (EC 4.6.1.1) (ATP PYROPHOSPHATE-LYASE) (ADENYLYL CYCLASE) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.162988\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.625183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADCY5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ADENYLATE CYCLASE, TYPE VI (EC 4.6.1.1) (ATP PYROPHOSPHATE-LYASE) (CA(2+)-INHIBITABLE ADENYLYL CYCLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.198584\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.761721\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704379\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADCY6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THYMIC STROMAL CO-TRANSPORTER. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.106987\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.410377\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260704182\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC46A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0410035\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.157329\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260622644\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SR RICH PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.479679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.84052\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260621455\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SFRS18\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.462971\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.77681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260563032\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT5B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
850\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.449791\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.72628\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260555066\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAT5A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CONSERVED OLIGOMERIC GOLGI COMPLEX COMPONENT 2 (LOW DENSITY LIPOPROTEIN RECEPTOR DEFECT C-COMPLEMENTING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0723993\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.277887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.260535038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COG2\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/